Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Atea Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 131 | 1 | 133 | +3 |
| Shares | 56.8M | 26.5K | 57.0M | +287.9K (+0.5%) |
| Value | $190.2M | $88.6K | $213.3M | +$23.2M (+12.2%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (24)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Wellington Management Group LLP | 286,233 | $958.9K |
| Congress Asset Management Co | 197,312 | $661.0K |
| Swiss National Bank | 161,800 | $542.0K |
| Candriam Luxembourg S.C.A. | 135,316 | $417.2K |
| Credit Suisse AG | 76,764 | $257.2K |
| PDT Partners, LLC | 65,954 | $220.9K |
| Ergoteles LLC | 50,500 | $169.2K |
| Virginia Retirement Systems Et Al | 42,200 | $141.4K |
| Martingale Asset Management L P | 40,100 | $134.3K |
| Janus Henderson Group PLC | 35,909 | $119.8K |
| XTX Topco Ltd | 32,630 | $109.3K |
| SG Americas Securities, LLC | 31,179 | $104.0K |
| State of Wyoming | 24,893 | $83.4K |
| Teacher Retirement System of Texas | 23,091 | $77.0K |
| Arizona State Retirement System | 21,719 | $72.8K |
| Meritage Portfolio Management | 21,476 | $72.0K |
| CM Wealth Advisors LLC | 19,400 | $64.0K |
| Caxton Associates LP | 16,998 | $56.9K |
| Bank of Montreal | 14,692 | $49.2K |
| Kapitalo Investimentos Ltda | 12,500 | $41.9K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 11,955 | $40.0K |
| Northwestern Mutual Wealth Management Co | 400 | $1.34K |
| Advisory Services Network, LLC | 200 | $670 |
| Quadrant Capital Group LLC | 58 | $195 |
Not filed for Q2 2023 yet (1)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 26,460 | $88.6K |